X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (112) 112
humans (98) 98
gastroenterology & hepatology (50) 50
prevent gastric-cancer (48) 48
helicobacter pylori (47) 47
cancer (34) 34
female (29) 29
male (28) 28
prevent colorectal adenomas (26) 26
randomized controlled-trial (24) 24
oncology (23) 23
adult (22) 22
animals (22) 22
helicobacter infections - drug therapy (22) 22
risk factors (22) 22
middle aged (21) 21
gastric cancer (19) 19
infection (19) 19
nonsteroidal antiinflammatory drugs (18) 18
prevention (18) 18
cost-effectiveness (17) 17
pharmacology & pharmacy (17) 17
abridged index medicus (16) 16
health aspects (16) 16
helicobacter infections - complications (16) 16
helicobacter infections - diagnosis (16) 16
care and treatment (15) 15
research (15) 15
stomach neoplasms - microbiology (15) 15
aged (14) 14
epidemiology (14) 14
eradication (14) 14
medicine, general & internal (14) 14
risk (14) 14
peptic-ulcer disease (13) 13
randomized-trial (13) 13
analysis (12) 12
anti-bacterial agents - therapeutic use (12) 12
breast-cancer (12) 12
cost-benefit analysis (12) 12
gastroenterology (12) 12
helicobacter infections - epidemiology (12) 12
medicine & public health (12) 12
peptic ulcer (12) 12
aspirin (11) 11
cell line, tumor (11) 11
disease (11) 11
helicobacter pylori - isolation & purification (11) 11
inflammation (11) 11
surgery (11) 11
endoscopy (10) 10
familial adenomatous polyposis (10) 10
helicobacter infections - microbiology (10) 10
intestinal metaplasia (10) 10
mice (10) 10
peptic ulcer - microbiology (10) 10
prevalence (10) 10
prevents (10) 10
stomach neoplasms - prevention & control (10) 10
treatment outcome (10) 10
diagnosis (9) 9
helicobacter infections (9) 9
review (9) 9
usage (9) 9
biochemistry & molecular biology (8) 8
colorectal-cancer (8) 8
drug therapy, combination (8) 8
duodenal-ulcer (8) 8
management (8) 8
metaanalysis (8) 8
physiological aspects (8) 8
studies (8) 8
triple therapy (8) 8
united-states (8) 8
bacteria (7) 7
clinical trials (7) 7
eradication therapy (7) 7
gastric-cancer (7) 7
helicobacter infections - economics (7) 7
medical colleges (7) 7
mortality (7) 7
mutation (7) 7
peptic-ulcer (7) 7
prostate-cancer (7) 7
tumors (7) 7
ulcers (7) 7
aged, 80 and over (6) 6
anti-inflammatory agents, non-steroidal - therapeutic use (6) 6
anti-ulcer agents - therapeutic use (6) 6
article (6) 6
breast cancer (6) 6
c-13-urea breath test (6) 6
cells (6) 6
chemotherapy (6) 6
clinical trials as topic (6) 6
colon cancer (6) 6
colorectal cancer (6) 6
dyspepsia (6) 6
dyspepsia - microbiology (6) 6
endoscopic resection (6) 6
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Gastroenterology, ISSN 0016-5085, 2009, Volume 137, Issue 5, pp. 1641 - 1648.e2
Journal Article
Journal Article
Alimentary Pharmacology & Therapeutics, ISSN 0269-2813, 04/2019, Volume 49, Issue 8, pp. 1013 - 1025
Background Helicobacter pylori eradication improves dyspeptic symptoms in 8%-10%, prevents peptic ulcer and may reduce the risk of gastric cancer. Availability... 
SOCIOECONOMIC POSITION | BASE-LINE | FUNCTIONAL DYSPEPSIA | PHARMACOLOGY & PHARMACY | ERADICATION THERAPY | INFECTION | QUALITY-OF-LIFE | HEALTH | PREVALENCE | GASTROENTEROLOGY & HEPATOLOGY | PEPTIC-ULCER DISEASE | PREVENT GASTRIC-CANCER | Prevention | Urea | Medical examination | Helicobacter pylori | Analysis | Peptic ulcer | Blood | Antiulcer drugs | Medical care, Cost of | Cancer
Journal Article
Gut, ISSN 0017-5749, 07/2018, Volume 67, Issue 7, pp. 1247 - 1260
ObjectiveGastric cancer is the third leading cause of cancer death worldwide and infection by Helicobacter pylori is the strongest risk factor. We have... 
EPIDERMAL GROWTH FACTOR | CHEMOPREVENTION | CHEMOKINES | GASTRIC CANCER | HELICOBACTER PYLORI | CELLS | KAPPA-B ACTIVATION | HEPATOCELLULAR-CARCINOMA | CANCER RISK | ERADICATION THERAPY | GEFITINIB PREVENTS | BETA-CATENIN | GASTROENTEROLOGY & HEPATOLOGY | INTERLEUKIN-8 | EGFR | CLINICOPATHOLOGICAL FEATURES | ErbB Receptors - antagonists & inhibitors | Mice, Inbred C57BL | Stomach Neoplasms - pathology | Antineoplastic Agents - therapeutic use | Epithelial Cells | Helicobacter Infections - pathology | Stomach Neoplasms - microbiology | Animals | Gerbillinae | Helicobacter pylori | Gastritis - pathology | Quinazolines - therapeutic use | Stomach Neoplasms - prevention & control | Gastritis - microbiology | Mice | Cell Culture Techniques | Gefitinib | Phosphorylation | Epithelial cells | Lung cancer | Mucosa | DNA damage | Infections | Kinases | Gene deletion | Stomach cancer | Carcinogenesis | Proteins | Epidermal growth factor | Clonal deletion | Gastroenterology | Peroxidase | Gastric cancer | Deoxyribonucleic acid--DNA | Dysplasia | Cytokines | Epidermal growth factor receptors | Phylogeography | Activator protein 1 | Transgenic mice | MAP kinase | Inflammation | Breast cancer | Insulin | Antibiotics | Protein kinase | Gastrin | Chemokines | Index Medicus | Abridged Index Medicus | chemoprevention | gastric cancer | chemokines
Journal Article
JAMA, ISSN 0098-7484, 02/2013, Volume 309, Issue 6, pp. 578 - 586
Journal Article
Journal of Gastrointestinal and Liver Diseases, ISSN 1841-8724, 06/2017, Volume 26, Issue 2, pp. 129 - 137
Background & Aims: H. pylori eradication is strongly affected by various factors, including the ongoing antibiotic resistance. We describe a "real life"... 
Levofloxacin | Clarythromicin | Chronic gastritis | Bismut | Pylera | COST-EFFECTIVENESS | GUIDELINES | ANTIBIOTIC-RESISTANCE | RANDOMIZED-TRIAL | SEQUENTIAL THERAPY | PREVENT GASTRIC-CANCER | CONSENSUS REPORT | QUADRUPLE THERAPY | levofloxacin | bismut | TRIPLE THERAPY | clarythromicin | GASTROENTEROLOGY & HEPATOLOGY | chronic gastritis | RESCUE THERAPY
Journal Article
Gastrointestinal Endoscopy, ISSN 0016-5107, 2015, Volume 82, Issue 4, pp. 593 - 599
Journal Article